An observational study in Lyme Disease, sponsored by Istanbul Gelisim University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Istanbul Gelisim University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this study is to investigate the relationships among balance, mobility, pain, fatigue, and quality of life in individuals diagnosed with Lyme disease. Lyme disease can cause various musculoskeletal and neurological symptoms that significantly impact physical function and overall well-being. In this observational study, participants will undergo clinical evaluations to assess balance performance, functional mobility levels, pain severity, fatigue levels, and health-related quality of life. The data obtained will help to better understand the clinical burden of Lyme disease and provide insight for developing targeted rehabilitation strategies.
98 studies on the registry are indexed under Lyme Disease; 27 are open to participants now.
This study's planned enrollment of 56 is below the median of 400 across 43 observational studies indexed under Lyme Disease.
Browse Lyme Disease studies →Istanbul Gelisim University is the lead sponsor of 65 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population consists of adult individuals diagnosed with Lyme disease recruited from outpatient clinics and demographically matched healthy control volunteers with no history of Lyme disease or major systemic disorders.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
For the Lyme disease group :
For Healthy individuals :
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Individuals diagnosed with Lyme disease who participate in balance, mobility, pain, fatigue, and quality of life evaluations.
Healthy control individuals with no history of Lyme disease who undergo the same evaluation protocol.
Mini-Mental State Examination (MMSE)
Evaluates five cognitive domains: temporal/spatial orientation, registration, attention and calculation, recall, and language/visuospatial skills. Total score ranges from 0 to 30, with higher scores indicating better cognitive function (24-30: normal, 18-23: mild impairment, 0-17: severe impairment).
Time frame: Baseline (Single evaluation at enrollment)
6-Minute Walk Test (6MWT)
Evaluates functional exercise capacity according to American Thoracic Society (ATS) guidelines. Participants walk the maximum distance possible in 6 minutes, with total distance recorded in meters.
Time frame: Baseline (Single evaluation at enrollment)
Modified Fatigue Impact Scale (MFIS)
Evaluates the impact of fatigue on physical, cognitive, and psychosocial functioning over the past four weeks. Contains 21 items scored on a 5-point Likert scale ranging from 0 (never) to 4 (almost always). Total score ranges from 0 to 84, with higher scores indicating a greater impact of fatigue on daily life and functioning.
Time frame: Baseline (Single evaluation at enrollment)
Fatigue Severity Scale (FSS)
Evaluates fatigue severity and its impact on activities of daily living over the past week. Consists of 9 items rated on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). The overall score is calculated as the average of the 9 item scores, ranging from 1 to 7, with higher mean scores indicating greater fatigue severity.
Time frame: Baseline (Single evaluation at enrollment)
Time Up And Go Test (TUG)
Evaluates functional mobility and dynamic balance. Starting from a seated position in a standard-height chair, the participants stands up upon the ''start'' command, walks 3 meters at a normal walking speed, turns around a designated point, walks back, and sits down again. The time required to complete the task is recorded in seconds using a stopwatch, with shorter completion times indicating better functional mobility and dynamic balance.
Time frame: Baseline (Single evaluation at enrollment)
McGill Pain Questionnaire (MPQ)
Evaluates pain intensity, sensory and affective qualities of pain, and its overall impact on daily life. Participants select word descriptors that best characterize their pain experience, from which the Pain Rating Index (PRI) is calculated. Higher scores indicate greater pain severity and a more significant negative impact of pain on daily life.
Time frame: Baseline (Single evaluation at enrollment)
Nottingham Health Profile (NHP)
Evaluates health-related quality of life across 38 items covering 6 domains: energy level, pain, emotional reactions, sleep, social isolation, and physical mobility. Participants answer each item with ''yes'' or ''no'' based on their current health status. Scores are calculated separately for each domain ranging from 0 to 100, with no total composite score. Higher scores indicate greater health problems and lower quality of life in that specific domain.
Time frame: Baseline (Single evaluation at enrollment)
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Apr 2027, 5 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Gelisim University